Sagimet Biosciences’ Post

View organization page for Sagimet Biosciences, graphic

3,360 followers

Today we reported our second quarter 2024 financial results and provided a corporate update. Highlights included the full Phase 2b FASCINATE-2 clinical trial results presented at #EASL for our lead program, denifanstat in MASH. To learn more about our recent advancements and upcoming milestones, read the full press release here: https://lnkd.in/gEdGWXzp #biotech #MASH #FASN #FASCINATE2

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics